CYTOMX THERAPEUTICS INC's ticker is CTMX and the CUSIP is 23284F105.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $145,061 | -20.5% | 112,450 | +5.9% | 0.08% | -17.6% |
| Q2 2023 | $182,578 | +20.7% | 106,150 | +5.9% | 0.09% | +15.2% |
| Q1 2023 | $151,302 | -3.0% | 100,200 | +395.9% | 0.08% | -9.2% |
| Q1 2021 | $156,000 | -7.7% | 20,207 | -21.7% | 0.09% | -13.0% |
| Q4 2020 | $169,000 | -67.6% | 25,807 | -67.2% | 0.10% | -69.0% |
| Q3 2020 | $522,000 | -27.4% | 78,561 | -9.0% | 0.32% | -41.5% |
| Q2 2020 | $719,000 | -4.9% | 86,311 | -12.5% | 0.55% | -19.1% |
| Q1 2020 | $756,000 | -3.9% | 98,611 | +4.2% | 0.68% | +17.4% |
| Q4 2019 | $787,000 | -36.4% | 94,661 | -43.6% | 0.58% | -44.1% |
| Q3 2019 | $1,238,000 | -27.9% | 167,811 | -0.5% | 1.04% | -23.4% |
| Q2 2019 | $1,716,000 | -24.5% | 168,611 | -20.4% | 1.36% | -30.9% |
| Q1 2019 | $2,274,000 | +22.1% | 211,906 | +71.3% | 1.96% | -4.2% |
| Q4 2018 | $1,863,000 | -10.2% | 123,711 | +10.3% | 2.05% | +10.2% |
| Q3 2018 | $2,075,000 | -17.1% | 112,186 | +2.4% | 1.86% | -22.5% |
| Q2 2018 | $2,504,000 | -18.3% | 109,525 | +1.7% | 2.40% | -23.7% |
| Q1 2018 | $3,065,000 | +15.3% | 107,725 | -14.5% | 3.15% | +17.5% |
| Q4 2017 | $2,659,000 | – | 125,975 | – | 2.68% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| TANG CAPITAL MANAGEMENT LLC | 6,450,000 | $8,320,500 | 1.17% |
| BVF INC/IL | 6,595,801 | $8,508,583 | 0.23% |
| Bronte Capital Management Pty Ltd. | 925,245 | $1,193,566 | 0.12% |
| Formidable Asset Management, LLC | 318,111 | $410,363 | 0.09% |
| Congress Park Capital LLC | 112,450 | $145,061 | 0.08% |
| Forefront Analytics, LLC | 49,421 | $63,754 | 0.04% |
| Ground Swell Capital, LLC | 10,966 | $14,146 | 0.02% |
| Clearline Capital LP | 196,583 | $253,592 | 0.02% |
| CORNERCAP INVESTMENT COUNSEL INC | 81,352 | $104,944 | 0.02% |
| ACADIAN ASSET MANAGEMENT LLC | 2,646,190 | $3,412 | 0.01% |